Back
Perspective Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
CATX
Perspective Therapeutics, Inc.
Last Price:
$5.3500
Seasonality Move:
10.42%
7 Day Trial
ALL ACCESS PASS
$
7
Perspective Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Perspective Therapeutics, Inc. has on average historically risen by 10769.3% based on the past 22 years of stock performance.
-
Perspective Therapeutics, Inc. has risen higher in 10 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Perspective Therapeutics, Inc. Stock Undervalued?The current Perspective Therapeutics, Inc. [CATX] share price is $5.4000. The Score for CATX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Perspective Therapeutics, Inc. has on average historically risen by 10769.3% based on the past 22 years of stock performance.
Perspective Therapeutics, Inc. Stock Rating
Buy
62
Perspective Therapeutics, Inc. (CATX)
is a Buy
Is Perspective Therapeutics, Inc. overpriced?
-
Perspective Therapeutics, Inc. has risen higher in 10 of those 22 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Perspective Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
6.1600
52-Week Low:
1.6000
Prediction Charts
Market Cap:
615.1M
Price in USD:
5.4000
Volume:
2M
Beta:
-73.2653
Technical Analysis
SMA50:
3.6580
SMA100:
3.2459
SMA200:
3.3469
52-Wk Change:
106.9%
Stock Predictions
-
Is Perspective Therapeutics, Inc. stock public?Yes, Perspective Therapeutics, Inc. is a publicly traded company.
-
What is the Perspective Therapeutics, Inc. stock quote today?The Perspective Therapeutics, Inc. stock price is 5.4000 USD today.
-
How to buy Perspective Therapeutics, Inc. stock online?You can buy Perspective Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-9 | 4.7200 | 4.8400 | 4.8700 | 4.3700 |
| Feb-10 | 4.8400 | 4.7400 | 5.0000 | 4.6843 |
| Feb-11 | 4.7100 | 4.8800 | 4.9050 | 4.4400 |
| Feb-12 | 4.8600 | 5.0200 | 5.0800 | 4.6700 |
| Feb-13 | 5.0300 | 4.7000 | 5.2000 | 4.6700 |
| Feb-17 | 4.7100 | 4.8500 | 4.8900 | 4.5300 |
| Feb-18 | 4.8300 | 5.0300 | 5.0350 | 4.6400 |
| Feb-19 | 5.2300 | 5.6500 | 5.6600 | 4.9920 |
| Feb-20 | 5.4000 | 5.6500 | 5.7900 | 5.2401 |
| Feb-23 | 5.5300 | 5.6000 | 5.9000 | 5.4600 |
| Feb-24 | 5.6300 | 5.4200 | 5.8500 | 5.3701 |
| Feb-25 | 5.4100 | 5.5500 | 5.5800 | 5.3600 |
| Feb-26 | 5.5300 | 5.0600 | 5.5300 | 5.0000 |
| Feb-27 | 5.0100 | 5.4000 | 5.4250 | 4.9100 |
Perspective Therapeutics, Inc. Earnings
Perspective Therapeutics, Inc. Earnings Report: Per Share Perspective Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Perspective Therapeutics, Inc. Forecast Revenue Growth
Perspective Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.19 per share.
* Perspective Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.